Alnylam Pharmaceuticals | ALNY - 销售毛利

金融业

USD

USD 5.13B

现金及等价物

USD 1.71B

USD 211.12M

USD 4.22B

USD 1.35B

USD 1.28B

USD 137.59M

USD 145.22M

2.23K

EPS每股收益

USD 1.99

股本和储备

USD 1.08B

USD 825.01M

债务利息支出

USD 69.29M

USD 26.63M

USD 2.48B

USD 38.83B

USD 205.99M

USD 898.54M

USD 137.59M

普通股股本

USD 133.44M

80.04

USD 221.65M

USD 1.17B

销售和管理费用

USD 282.51M

USD 200.15M

贸易债权人

USD 126.63M

应收帐款人

USD 883.96M

	销售毛利	更改		日
Acadia Pharmaceuticals	USD 243.27M		14.49M	2026-03
Agios Pharmaceuticals	USD 19.43M		1.34M	2026-03
Alnylam Pharmaceuticals	USD 825M		4.3M	2026-03
Amgen	USD 6.89B		415M	2025-12
Arrowhead Research	USD 264.03M		7.56M	2025-12
BioCryst Pharmaceuticals	USD 153.05M		4.16M	2025-12
BioMarin Pharmaceutical	USD 571.21M		141.8M	2026-03
Incyte	USD 1.17B		217.51M	2026-03
Ionis Pharmaceuticals	USD 243M		48M	2026-03
Moderna	USD -566M		792M	2026-03
Neurocrine Biosciences	USD 800.7M		12.8M	2026-03
Novartis	USD 10.82B		694M	2025-09
PTC Therapeutics	USD 232.94M		84.56M	2026-03
Regeneron Pharmaceuticals	USD 2.94B		363.7M	2026-03
Sangamo BioSciences	-2.39M		1.09M	2024-06
Sanofi	EUR 8.45B		3.02B	2025-12
Sarepta Therapeutics	USD 621.34M		577.79M	2026-03
Takeda	JPY 688.84B		101.71B	2026-03
Tectonic Therapeutic	USD 0		0	2025-03
Ultragenyx Pharmaceutical	USD 106M		72M	2026-03
Vertex Pharmaceuticals	USD 2.6B		121.7M	2026-03
Xencor	USD 21M		22.61M	2025-09